EXEL |
Exelixis, Inc. |
0 |
4.37% |
|
|
|
|
|
N/A |
0.00% |
32.60% |
25.01% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
4.23% |
|
|
|
|
|
N/A |
0.00% |
435.76% |
49.91% |
---|
NTRA |
Natera, Inc. |
0 |
4.19% |
|
|
|
|
|
N/A |
0.00% |
53.38% |
31.33% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
0 |
4.07% |
|
|
|
|
|
N/A |
0.00% |
27.77% |
8.48% |
---|
ARGX |
argenx SE |
0 |
3.94% |
|
|
|
|
|
N/A |
0.00% |
29.52% |
28.33% |
---|
CORT |
Corcept Therapeutics Incorporated |
0 |
3.82% |
|
|
|
|
|
N/A |
0.00% |
42.07% |
19.56% |
---|
ITCI |
Intra-Cellular Therapies, Inc. |
|
3.79% |
|
|
|
|
|
|
|
|
|
---|
GILD |
Gilead Sciences, Inc. |
0 |
3.74% |
|
|
|
|
|
N/A |
0.00% |
29.35% |
27.52% |
---|
INCY |
Incyte Corporation |
0 |
3.59% |
|
|
|
|
|
N/A |
0.00% |
29.49% |
27.75% |
---|
RGEN |
Repligen Corporation |
0 |
3.57% |
|
|
|
|
|
N/A |
0.00% |
46.67% |
7.31% |
---|
WAT |
Waters Corporation |
0 |
3.57% |
|
|
|
|
|
N/A |
0.00% |
42.26% |
46.25% |
---|
CPRX |
Catalyst Pharmaceuticals, Inc. |
0 |
3.55% |
|
|
|
|
|
N/A |
0.00% |
53.58% |
49.52% |
---|
ALKS |
Alkermes plc |
0 |
3.42% |
|
|
|
|
|
N/A |
0.00% |
58.11% |
42.47% |
---|
UTHR |
United Therapeutics Corporation |
0 |
3.39% |
|
|
|
|
|
N/A |
0.00% |
58.67% |
104.61% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
0 |
3.36% |
|
|
|
|
|
N/A |
0.00% |
117.60% |
53.76% |
---|
BNTX |
BioNTech SE |
0 |
3.25% |
|
|
|
|
|
N/A |
0.00% |
43.87% |
30.54% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
0 |
3.21% |
|
|
|
|
|
N/A |
0.00% |
39.49% |
50.37% |
---|
ILMN |
Illumina, Inc. |
0 |
3.16% |
|
|
|
|
|
N/A |
0.00% |
39.56% |
23.84% |
---|
BRKR |
Bruker Corporation |
0 |
3.13% |
|
|
|
|
|
N/A |
0.00% |
63.73% |
71.40% |
---|
HALO |
Halozyme Therapeutics, Inc. |
0 |
3.10% |
|
|
|
|
|
N/A |
0.00% |
42.17% |
37.99% |
---|
GMAB |
Genmab A/S |
0 |
3.05% |
|
|
|
|
|
N/A |
0.00% |
125.36% |
33.50% |
---|
MTD |
Mettler-Toledo International Inc. |
0 |
2.90% |
|
|
|
|
|
N/A |
0.00% |
31.59% |
18.47% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
2.88% |
|
|
|
|
|
N/A |
0.00% |
35.91% |
45.64% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
2.85% |
|
|
|
|
|
N/A |
0.00% |
33.44% |
22.47% |
---|
BIIB |
Biogen Inc. |
0 |
2.79% |
|
|
|
|
|
N/A |
0.00% |
28.33% |
18.82% |
---|
AMGN |
Amgen Inc. |
0 |
2.73% |
|
|
|
|
|
N/A |
0.00% |
27.10% |
20.21% |
---|
EXAS |
Exact Sciences Corporation |
0 |
2.72% |
|
|
|
|
|
N/A |
0.00% |
61.77% |
68.33% |
---|
BGNE |
BeiGene, Ltd. (ADR) |
|
2.69% |
|
|
|
|
|
|
|
|
|
---|
MRNA |
Moderna, Inc. |
0 |
2.45% |
|
|
|
|
|
N/A |
0.00% |
56.54% |
10.47% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
2.41% |
|
|
|
|
|
N/A |
0.00% |
35.99% |
35.90% |
---|
|
US Dollar |
|
0.08% |
|
|
|
|
|
|
|
|
|
---|